Colonic mucosal lesions associated with low-dose aspirin: A case control study

References

• Antiplatelet Trialist' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81–106.
   PubMedGoogle Scholar
• Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physician's Health Study. N Engl J Med 1989;321:129–35.
   PubMed Web of Science ®Google Scholar
• The SALT Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mgr aspirin as secondary prophylaxis after cerebrovascular events. Lancet 1991;338:1345–53.
   PubMed Web of Science ®Google Scholar
• Lorenz RL, Schacky CV, Weber M, Meister W, Kotzur J, Reichardt B, Improved aortocoronary bypass patency by low-dose aspirin (100 mgr. daily): effects of platelet aggregation and thromboxane formation. Lancet 1984;1:1261–4.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241–6.
   PubMed Web of Science ®Google Scholar
• Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004;56:387–437.
   PubMed Web of Science ®Google Scholar
• Loll PJ, Picot D, Garavoto RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 1995;2:637–43.
   PubMedGoogle Scholar
• Oullet M, Riendeau D, Percival MD. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxgenase-1 inactivation by aspirin. Proc Nat Acad Sci USA 2001;98:14583–8.
   PubMedGoogle Scholar
• Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet thrapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81–106.
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71–86.
   PubMed Web of Science ®Google Scholar
• Yeomans ND, Lanas AI, Talley NJ, Thomson AB, Daneshjoo R, Eriksson B, Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005;22:795–801.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Iwakiri R, Hara M, Ootani H, Shimoda R, Tsunada S, Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J Gastroenterol 2009;44:912–18.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832–47.
   PubMed Web of Science ®Google Scholar
• Davies NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995;38:1311–21.
   PubMed Web of Science ®Google Scholar
• Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs. Arch Intern Med 1992;152:625–32.
   PubMedGoogle Scholar
• Shibuya T, Ohkusa T, Yokoyama T, Harada A, Beppu K, Sakamoto N, Colonic mucosal lesions associated with long-term or short-term administration of nonsteroidal anti-inflammatory drugs. Colorectal Dis 2010;12:1113–21.
   PubMedGoogle Scholar
• Wilcox CM, Alexander LN, Cotsonis GA, Clark WS. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997;42:990–7.
   PubMed Web of Science ®Google Scholar
• Stolte M, Karimi D, Vieth M, Volkholz H, Dirschmid K, Rappel S, Strictures, diaphragms, erosions or ulcerations of ischemic type in the colon should always prompt consideration of nonsteroidal anti-inflammatory drug-induced lesions. World J Gastroenterol 2005;11:5828–33.
   PubMedGoogle Scholar
• Kaneko E, Munakata A, Iwao Y, Katsumata T, Tada M, Hanai H, Guideline for prevention of accidents during colonoscopic procedures. Gastroenterol Endosc 2003;45:1939–45. (In Japanese).
   Google Scholar
• Yamada A, Sugimoto T, Kondo S, Ohta M, Watabe H, Maeda S, Assessment of the risk factors for colonic diverticular hemorrhage. Dis Colon Rectum 2008;51:116–20.
   PubMed Web of Science ®Google Scholar
• Tsuruoka N, Iwakiri R, Hara M, Shirahama N, Sakata Y, Miyahara K, NSAIDs is a significant risk factor for colonic diverticular hemorrhage in elder patients: evaluation by a case–control study. J Gastroenterol Hepatol 2010. doi: 10.1111/j.1440-1746.2010.06610.x. [Epub ahead of print].
   Google Scholar
• Aguwa CN. Effects of exogenous administration of female sex hormones on gastric secretion and ulcer formation in the rat. Eur J Pharmacol 1984;104:79–84.
   PubMed Web of Science ®Google Scholar
• Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 2004;291:2433–40.
   PubMed Web of Science ®Google Scholar
• Kurahara K, Matsumoto T, Iida M, Honda K, Yao T, Fujishima M. Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastroenterol 2001;96:473–80.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG, Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005;3:133–41.
   PubMed Web of Science ®Google Scholar
• Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol 2008;43:270–6.
   PubMed Web of Science ®Google Scholar
• Laine L, Smith R, Min K, Chen C, Dubois RW. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006;24:751–67.
   PubMed Web of Science ®Google Scholar
• Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 2002;162:169–75.
   PubMed Web of Science ®Google Scholar